Drug Trial Radar · NCT07441005
Comparative Efficacy of Topical Oxiconazole Cream (1%) Versus Topical Clotrimazole Cream (1%) in the Treatment of Tinea CrurisAbstract
Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
386
Actual
Start
May 15, 2025
Primary completion
Oct 15, 2025
Study completion Oct 15, 2025
Sponsor
- Lead sponsor
- Hayat Abad Medical Complex, PeshawarGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- First posted
- Feb 27, 2026
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is conducted to compare the efficacy of topical oxiconazole 1% cream versus topical clotrimazole 1% cream in patients with tinea cruris.
Conditions
- Tinea Cruris
Interventions
Topical Oxiconazole creamDrug
Group A will recieve topical Oxiconazole
Topical Clotrimazole creamDrug
Group B will recieve topical clotrimazole
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of improvement iTime frame: Six months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hayatabad medal Complex
Peshawar, KPK, Pakistan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.